Participate in a Clinical Trial
Without the participation of people with MS, it would be impossible to develop new and better therapies and other interventions.
A Health Action Process Approach Online Intervention for People With Multiple Sclerosis
The purpose of this study is to implement the person-centered internet-based Health Action Process Approach to promoting physical activity in people with Multiple Sclerosis (i.e., eHAPA-MS online intervention) and assess the intervention's effectiveness and adherence.
Accepts Healthy Volunteers
Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms
An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.
An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.
Searching Both is inclusive of interventional and observational studies.
|Eligible Ages||18 Years and Over|
More Inclusion & Exclusion Criteria
- - are 18 years old and above; - have not maintained 30 minutes of MVPA accumulated per day for 2 days of the week during the previous 6 months; - have a score < 24 for the leisure score index of the Godin Leisure-Time Exercise Questionnaire; - be relapse-free for the past 30 days; - show low risk for contraindications of PA indicated by no more than a single 'yes' response on the Physical Activity Readiness Questionnaire; - be able to walk with or without an assistive device; - are willing to be randomized to an intervention or control group, complete the surveys and questionnaires, and wear an accelerometer during the intervention period; - have Internet access.
This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.
Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.
Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.
Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.
Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.
The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.
|University of Illinois at Urbana-Champaign|
The person who is responsible for the scientific and technical direction of the entire clinical study.
|Chungyi Chiu, PhD|
|Principal Investigator Affiliation||University of Illinois Urbana-Champaign|
Category of organization(s) involved as sponsor (and collaborator) supporting the trial.
The disease, disorder, syndrome, illness, or injury that is being studied.
Arms & Interventions
Experimental: MSPA eClass
No Intervention: Waiting list
Behavioral: - MSPA eClass
An 8-week MS-HAPA Internet-based intervention
Contact a Trial Team
If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.
University of Illinois Urbana-Champaign
Champaign, Illinois, 61820
Posting a Trial
If you would like us to post a study on these pages, please email firstname.lastname@example.org to find out what information you need to submit for review.